Toll Free: 1-888-928-9744

ProMetic Life Sciences Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

ProMetic Life Sciences Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'ProMetic Life Sciences Inc. - Product Pipeline Review - 2014', provides an overview of the ProMetic Life Sciences Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ProMetic Life Sciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of ProMetic Life Sciences Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of ProMetic Life Sciences Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the ProMetic Life Sciences Inc.'s pipeline products

Reasons to buy

- Evaluate ProMetic Life Sciences Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of ProMetic Life Sciences Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the ProMetic Life Sciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of ProMetic Life Sciences Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of ProMetic Life Sciences Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of ProMetic Life Sciences Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ProMetic Life Sciences Inc. Snapshot 5
ProMetic Life Sciences Inc. Overview 5
Key Information 5
Key Facts 5
ProMetic Life Sciences Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
ProMetic Life Sciences Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
ProMetic Life Sciences Inc. - Pipeline Products Glance 13
ProMetic Life Sciences Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
ProMetic Life Sciences Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
ProMetic Life Sciences Inc. - Drug Profiles 15
PBI-1402 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PBI-1522 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PBI-1607 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PBI-1668 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PBI-1737 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PBI-4050 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PBI-4419 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PBI-4494 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ProMetic Life Sciences Inc. - Pipeline Analysis 24
ProMetic Life Sciences Inc. - Pipeline Products by Route of Administration 24
ProMetic Life Sciences Inc. - Pipeline Products by Molecule Type 25
ProMetic Life Sciences Inc. - Recent Pipeline Updates 26
ProMetic Life Sciences Inc. - Dormant Projects 29
ProMetic Life Sciences Inc. - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33
List of Tables
ProMetic Life Sciences Inc., Key Information 5
ProMetic Life Sciences Inc., Key Facts 5
ProMetic Life Sciences Inc. - Pipeline by Indication, 2014 8
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2014 9
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2014 10
ProMetic Life Sciences Inc. - Partnered Products in Pipeline, 2014 11
ProMetic Life Sciences Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12
ProMetic Life Sciences Inc. - Phase II, 2014 13
ProMetic Life Sciences Inc. - Preclinical, 2014 14
ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2014 24
ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2014 25
ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2014 26
ProMetic Life Sciences Inc. - Dormant Developmental Projects,2014 29
ProMetic Life Sciences Inc., Other Locations 30
ProMetic Life Sciences Inc., Subsidiaries 31 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify